Isomorphic Labs raises $5 billion Series C led by Greenoaks and Sequoia
Isomorphic Labs, the AI drug-design company spun out of Google DeepMind, has raised $5 billion in Series C funding, according to The Defiant and HedgeCo.Net. Both posts report the round was co-led by Greenoaks and Sequoia Capital, and The Defiant adds that Alphabet invested again as the company prepares its first therapeutic programs for clinical trials.
Why “Unverified”
- 2 independent sources (The Defiant, HedgeCo.Net), but no primary confirmation
2 independent source groups across 2 posts · evidence score 71/100. How labels work
What the sources claim
-
Isomorphic Labs raised $5 billion in Series C funding.
“has raised $5 billion in Series C funding”
HedgeCo.Net -
The Series C round was co-led by Greenoaks and Sequoia Capital.
“The round was co-led by Greenoaks and Sequoia Capital”
HedgeCo.Net -
Greenoaks and Sequoia co-led the Series C as Isomorphic prepares its first therapeutic programs for clinical trials.
“Greenoaks and Sequoia co-led the Series C as Isomorphic prepares its first therapeutic programs for clinical trials”
The Defiant -
Alphabet invested again in the round.
“with Alphabet investing again”
The Defiant -
Isomorphic Labs is the AI drug-design company spun out of Google DeepMind in 2021.
“the AI drug-design company spun out of Google DeepMind in 2021”
HedgeCo.Net
Sources
More in AI & Tech
Embed this page
Summary and claims extracted by AI with prompt analyze-story@5 on 2026-11-18 12:00 UTC. Labels are computed from the sources, not by the model.